Kura Oncology
KURA· Manufacturing· Fiscal year ends in December
Troy E. Wilson, Ph.D., J.D. is the CEO of Kura Oncology and was paid $4.7M in FY2025 (Dec).
Executives3
See all- 1Troy E. Wilson, Ph.D., J.D.President and Chief Executive OfficerFY2025
- 2Brian PowlChief Commercial OfficerFY2025
- 3Kathleen FordChief Operating OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allKura Oncology paid its 3 named executives $9.3M in total in FY2025 (Dec). CEO Troy E. Wilson, Ph.D., J.D. was paid $4.7M of that.
| Name | |||
|---|---|---|---|
| Troy E. Wilson, Ph.D., J.D.President and Chief Executive Officer | Not disclosed | Not disclosed | |
| Brian PowlChief Commercial Officer | Not disclosed | Not disclosed | |
| Kathleen FordChief Operating Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers18
See allThe FY2025 (Dec) proxy of Kura Oncology names 18 peer companies for pay. Among Kura Oncology and these peers, CEO pay was 8th highest of 9 and total shareholder return was 7th highest of 9.
8th highest of 9in Kura Oncology and its pay peers, FY2025 (Dec) by CEO pay:
7th highest of 9in Kura Oncology and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board5
See all- Thomas MalleyDirector · 10 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive
- Mary T. SzelaDirector · 7 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive
- Carol SchaferDirector · 4 yr on the boardIndependentAudit (Chair), Nominating and Corporate Governance—Paid as an executive
- Helen CollinsDirector · 4 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
- Michael J. VasconcellesDirector · 1 yr on the boardIndependentCompensation—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 10, 2026 | FY2025 |
| Annual report | 10-K | Mar 5, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 11, 2025 | FY2024 |
| Annual report | 10-K | Feb 28, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 12, 2024 | FY2023 |
| Annual report | 10-K | Feb 27, 2024 | FY2023 |